Pfizer receives distinction of the Argentina society of Cardiology for its contribution cientÃfico-educacional.
during the academic Act entity.
-the plate is a recognition of the continued support to the activity of the institution to improve the cardiovascular health of Argentines.
Buenos Aires, December 2009. – Pfizer Argentina has just received a plaque in recognition of his contribution to the task CientÃfico-Educacional by the Argentina society of Cardiology (SAC). This distinction was awarded during the academic of the entity, which also occurred during the inauguration of the new authorities.
Us, is proud to receive this recognition, which represents our commitment to people’s cardiovascular health ”, said Marcelo BugarÃn, the heart line product manager of Pfizer Argentina, who received the prize. from the company promote scientific research to increase knowledge about diseases of the heart, and promote awareness of the public to prevent or to detect cardiovascular disorders. SAC makes a fundamental work in both areas, and thus that for years we join efforts to facilitate their activities ”.
As part of the Mission of Pfizer, which consists of applying science and global resources to improve health and well-being at every stage of life, Pfizer has established itself as the company offered more support to scientific development in the Argentina. Is present supporting scientific meetings throughout the country, from La Quiaca to Ushuaia, with a major logistical effort. Also collaborates on an ongoing basis with the training of resident doctors, and supports the activities of the SAC through auspices and agreements of cooperation for the third consecutive year.
The SAC carries out an intense training to physicians; endorses the certification of medical cardiologists and conducts a training program for the recertification. also, produces epidemiological and clinical research studies and consensus for the diagnosis and treatment of cardiovascular diseases. Through the Foundation Cardiologica Argentina, educates the general population to prevent cardiovascular disease, and teaches courses in cardiopulmonary resuscitation.
Pfizer Inc: working together for a healthier world
Pfizer, founded in 1849, is the first biopharmaceutical company in the world to develop new approaches in the field of health. We are dedicated to discovering, developing, producing and distributing medicines for sale under prescription of quality, safe and effective for treating or preventing diseases in human and animals. We also work with health care providers, Governments and local organizations from different countries to facilitate access to our medicines and to provide better health care. Employees of Pfizer, working in more than 90 countries, strive every day so that the patient longer and enjoy a better quality of life and the economic and social impact of the disease had been reduced to level world.
